MedTrace Logo

Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer

NCT00061867 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2013-05-30

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, use different ways to stop tumor cells from dividing so they stop growing or die. Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. Combining liposomal doxorubicin with microwave thermotherapy may kill more tumor cells.

PURPOSE: This phase I trial is studying the side effects and best dose of liposomal doxorubicin when given together with microwave thermotherapy in treating patients with prostate cancer.

Conditions

Interventions

DRUG

pegylated liposomal doxorubicin hydrochloride

PROCEDURE

hyperthermia treatment

Sponsors & Collaborators

  • Imunon

    lead INDUSTRY

Principal Investigators

  • Catherine Van Doren, RN · Imunon

Study Design

Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Completion
2005-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00061867 on ClinicalTrials.gov